Scientific paper - Letter
Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech) COVID-19 vaccine
Dermatologic Therapy, 35 (2022), 11; e15791. https://doi.org/10.1111/dth.15791

Hlača, Nika; Žagar, Tina; Kaštelan, Marija; Peternel, Sandra; Brajac, Ines; Dujmović‐Hasanbegović, Katarina; Prpić‐Massari, Larisa

Linked objects
COVID-19 (zbirka 2.) | Virtual collection
Cite this document

Hlača, N., Žagar, T., Kaštelan, M., Peternel, S., Brajac, I., Dujmović‐Hasanbegović, K. & Prpić‐Massari, L. (2022). Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech) COVID-19 vaccine. Dermatologic Therapy, 35. (11). doi: 10.1111/dth.15791

Hlača, Nika, et al. "Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech) COVID-19 vaccine." Dermatologic Therapy, vol. 35, no. 11, 2022. https://doi.org/10.1111/dth.15791

Hlača, Nika, Tina Žagar, Marija Kaštelan, Sandra Peternel, Ines Brajac, Katarina Dujmović‐Hasanbegović and Larisa Prpić‐Massari. "Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech) COVID-19 vaccine." Dermatologic Therapy 35, no. 11 (2022). https://doi.org/10.1111/dth.15791

Hlača, N., et al. (2022) 'Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech) COVID-19 vaccine', Dermatologic Therapy, 35(11). doi: 10.1111/dth.15791

Hlača N, Žagar T, Kaštelan M, Peternel S, Brajac I, Dujmović‐Hasanbegović K, and sur.. Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech) COVID-19 vaccine. Dermatologic Therapy [Internet]. 2022 September 07 [cited 2024 July 11];35(11). doi: 10.1111/dth.15791

N. Hlača, et al., "Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech) COVID-19 vaccine", Dermatologic Therapy, vol. 35, no. 11, September 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:387055. [Accessed: 11 July 2024]

Please login to the repository to save this object to your list.